Amorphous Nanoparticles for Drug Delivery of Poorly Water-Soluble Compounds

Jan 18, 2022, 12:00:00 AM

Ascendia Pharmaceuticals Participates in Virtual Nasdaq Opening Bell Ceremony Celebrating J.P. Morgan Healthcare Conference

Jan 14, 2022, 12:00:00 AM

GMP Requirements for Clinical Trial Material: An Overview

Dec 22, 2021, 12:00:00 AM

Biologics CDMO: What It Is & Why You Need One in This Market

Dec 8, 2021, 12:00:00 AM

Accelerating the Biologics Development Process

Nov 24, 2021, 12:00:00 AM

Aseptic Pharmaceutical Manufacturing: How It Works

Nov 17, 2021, 12:00:00 AM

Formulation Development: Why It’s So Important

Nov 10, 2021, 12:00:00 AM

Understanding Emulsion Formulation

Nov 8, 2021, 12:00:00 AM

Sterile Injectable Drugs Defined

Nov 3, 2021, 12:00:00 AM

Biologics vs. Small Molecule Drugs: Which Are Better?

Oct 27, 2021, 12:00:00 AM

Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again

Oct 12, 2021, 12:00:00 AM

Ascendia to Highlight CDMO Services at AAPS PharmSci360

Oct 7, 2021, 12:00:00 AM